Epigenetics and genomics in Klinefelter syndrome

Area of Science:

• Genetics
• Endocrinology
• Molecular Biology

Background:

• Klinefelter syndrome (KS), first described in 1942, exhibits significant inter-individual variability in its phenotypic presentation.
• The precise impact of the additional X chromosome on the genome in KS remains incompletely understood.
• Existing literature suggests multiple concurrent genetic mechanisms contribute to KS phenotype and variable expressivity.

Purpose of the Study:

• To review current understanding of genetic mechanisms underlying Klinefelter syndrome.
• To explore recent advances in the study of the KS genome, epigenome, and transcriptome.
• To link these molecular insights to clinical heterogeneity and phenotype in KS.

Main Methods:

• Literature review of existing studies on Klinefelter syndrome.
• Analysis of genetic, epigenetic, and transcriptomic data related to KS.
• Correlation of molecular findings with observed clinical phenotypes and heterogeneity.

Main Results:

• The phenotypic variability in KS is not attributable to a single genetic mechanism.
• Multiple genetic factors, alongside epigenetic and transcriptomic alterations, likely contribute to KS.
• Advances are being made in understanding the complex molecular underpinnings of KS.

Conclusions:

• Unraveling the complex genetics of Klinefelter syndrome is essential for understanding its clinical heterogeneity.
• Future research integrating clinical, genomic, epigenomic, and transcriptomic data is needed.
• Understanding KS genetics may enable polygenic risk scores for disease susceptibility prediction and clinical risk stratification.